Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy
Clinical trial NCT02577393 · UNKNOWN
Trial details
- NCT number
- NCT02577393
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2022-06-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.